Researchers identified MTR4, an RNA helicase and nuclear exosome cofactor, as a determinant of endothelial cell youthfulness that declines sharply in senescent human endothelial cells and aged mouse aortas. Loss occurs through SYVN1-mediated ubiquitination and proteasomal degradation, destabilizing the BUB3–BUBR1 axis and triggering senescence; restoring MTR4 reversed vascular dysfunction and multi-organ aging phenotypes in mice and markedly extended lifespan in C. elegans. The vascular endothelium emerges as a tractable upstream control point for systemic aging.
Key Points
- MTR4 protein declines in senescent endothelium and aged mouse aortas
- SYVN1-driven K638 ubiquitination degrades MTR4, destabilizing BUB3 and BUBR1
- Endothelial MTR4 restoration reversed vascular aging; worm overexpression extended lifespan
Longevity Analysis
The endothelium sits at the interface of every organ's blood supply, so its senescence propagates dysfunction far beyond the vessel wall — a mechanistic explanation for why multi-organ decline often tracks with vascular aging. Targeting the degradation step rather than the downstream phenotype reframes the intervention: removing the proteolytic pressure that strips a protective factor is distinct from supplementing what has already been lost. For clinicians, it reinforces that circulatory integrity, tissue renewal capacity, and systemic resilience are governed by shared upstream machinery worth monitoring long before overt vascular disease appears.
Original published by Wiley Aging Cell, by Zhenyuan Guo, Zhiqiang Chen, Jiaqi Sun, Xiaojun Zhou, Chengzhi Ni, Yuxiang Zhang, Pengfei Qiang, Lu Zhang .